BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 954 filers reported holding BAXTER INTL INC in Q1 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $691,000 | -1.7% | 8,512 | +1.3% | 0.03% | +23.1% |
Q4 2019 | $703,000 | -11.0% | 8,402 | -7.0% | 0.03% | -16.1% |
Q3 2019 | $790,000 | +14.3% | 9,032 | +7.1% | 0.03% | +10.7% |
Q2 2019 | $691,000 | -15.7% | 8,437 | -16.4% | 0.03% | -20.0% |
Q1 2019 | $820,000 | +23.5% | 10,087 | 0.0% | 0.04% | +6.1% |
Q4 2018 | $664,000 | -15.4% | 10,087 | -1.0% | 0.03% | 0.0% |
Q3 2018 | $785,000 | +6.9% | 10,187 | +2.5% | 0.03% | 0.0% |
Q2 2018 | $734,000 | +33.0% | 9,937 | +17.1% | 0.03% | +26.9% |
Q1 2018 | $552,000 | +9.7% | 8,487 | +9.1% | 0.03% | +18.2% |
Q4 2017 | $503,000 | +85.6% | 7,780 | +79.9% | 0.02% | +69.2% |
Q3 2017 | $271,000 | -41.1% | 4,325 | -43.1% | 0.01% | -43.5% |
Q2 2017 | $460,000 | +34.9% | 7,604 | +15.6% | 0.02% | -11.5% |
Q1 2017 | $341,000 | +15.6% | 6,580 | -1.0% | 0.03% | +13.0% |
Q4 2016 | $295,000 | -9.8% | 6,646 | -3.3% | 0.02% | -11.5% |
Q3 2016 | $327,000 | +1.9% | 6,871 | -3.2% | 0.03% | 0.0% |
Q2 2016 | $321,000 | +7.7% | 7,098 | -2.0% | 0.03% | +4.0% |
Q1 2016 | $298,000 | +8.0% | 7,245 | 0.0% | 0.02% | +4.2% |
Q4 2015 | $276,000 | +7.4% | 7,245 | -7.4% | 0.02% | 0.0% |
Q3 2015 | $257,000 | -51.0% | 7,820 | +4.3% | 0.02% | -22.6% |
Q2 2015 | $524,000 | +1.4% | 7,500 | -0.7% | 0.03% | -6.1% |
Q1 2015 | $517,000 | -20.8% | 7,550 | -15.2% | 0.03% | -23.3% |
Q4 2014 | $653,000 | +31.4% | 8,908 | +28.7% | 0.04% | +26.5% |
Q3 2014 | $497,000 | -0.6% | 6,920 | 0.0% | 0.03% | 0.0% |
Q2 2014 | $500,000 | -1.8% | 6,920 | 0.0% | 0.03% | -8.1% |
Q1 2014 | $509,000 | +42.6% | 6,920 | +34.9% | 0.04% | +37.0% |
Q4 2013 | $357,000 | +8.2% | 5,130 | +2.0% | 0.03% | 0.0% |
Q3 2013 | $330,000 | -8.8% | 5,030 | -3.8% | 0.03% | -15.6% |
Q2 2013 | $362,000 | – | 5,230 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 41,000,000 | $2,482,140,000 | 22.00% |
THUNDERBIRD PARTNERS LLP | 1,711,643 | $103,623,000 | 12.17% |
SECTOR GAMMA AS | 1,070,333 | $64,798,000 | 9.42% |
Veritas Asset Management LLP | 10,179,102 | $616,243,000 | 4.81% |
13D Management LLC | 194,807 | $11,794,000 | 4.18% |
Progressive Investment Management Corp | 78,316 | $4,741,000 | 3.69% |
Aristotle Capital Management, LLC | 6,846,307 | $414,476,000 | 3.46% |
ARGENT CAPITAL MANAGEMENT LLC | 1,394,075 | $84,397,000 | 3.37% |
Lipe & Dalton | 80,073 | $4,848,000 | 3.14% |
PURA VIDA INVESTMENTS, LLC | 125,000 | $7,568,000 | 3.00% |